Punch & Associates Investment Management, Inc. Iridex Corp Transaction History

Punch & Associates Investment Management, Inc.

$1.62 Billion
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.41 - $3.41 $8,353 - $11,819	3,466 Added 2.17%	163,466 $394,000
Q2 2022 Aug 15, 2022	BUY	$2.48 - $4.66 $16,120 - $30,290	6,500 Added 4.23%	160,000 $411,000
Q1 2022 May 16, 2022	BUY	$3.99 - $6.42 $173,469 - $279,115	43,476 Added 39.52%	153,500 $711,000
Q4 2021 Feb 15, 2022	BUY	$5.62 - $9.37 $618,334 - $1.03 Million	110,024 New	110,024 $672,000

Others Institutions Holding IRIX

# of Institutions

Shares Held

3.25M

Call Options Held

500

Put Options Held

61.3K

Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX

1M
Shares

$1.39 Million
5.28% of portfolio
Vanguard Group Inc Valley Forge, PA

561K
Shares

$779,923
0.0% of portfolio
Amh Equity LTD

461K
Shares

$640,512
1.39% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

405K
Shares

$562,894
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

129K
Shares

$179,437
0.0% of portfolio

View Full List

About IRIDEX CORP

Ticker IRIX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 15,985,600
Market Cap $22.2M
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...

More about IRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Punch & Associates Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Punch & Associates Investment Management, Inc. with notifications on news.

Account